首页> 外文期刊>Clinical neuropharmacology >In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine.
【24h】

In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine.

机译:己酮可可碱,吡乙酰胺和长春西汀的体外抗氧化性能。

获取原文
获取原文并翻译 | 示例
       

摘要

Oxygen-free radicals play an important role in several physiologic and pathophysiologic processes. In pathologic circumstances, they can modify and damage biologic systems. Because oxygen-free radicals are involved in a wide range of diseases (cerebrovascular, cardiovascular, etc.), scavenging these radicals should be considered as an important therapeutic approach. In our in vitro study, we investigated the antioxidant capacity of three drugs: pentoxiphylline (Sigma Aldrich, St. Louis, MO, USA) piracetam (Sigma Aldrich), and vinpocetine (Richter Gedeon RT, Budapest, Hungary). Phenazine methosulphate was applied to generate free radicals, increasing red blood cell rigidity. Filtration technique and potassium leaking were used to detect the cellular damage and the scavenging effect of the examined drugs. According to our results, at human therapeutic serum concentration, only vinpocetine (Richter Gedeon RT) had significant (p < 0.01) scavenging activity with a protective effect that increased further at higher concentrations. Pentoxiphylline (Sigma Aldrich) and piracetam (Sigma Aldrich) did not have significant antioxidant capacity at therapeutic concentrations, but increasing their concentrations (pentoxiphylline at 100-times, and piracetam at 10-times higher concentrations) led to a significant (p < 0.01) scavenger effect. Our findings suggest that this pronounced antioxidant effect of vinpocetine and even the milder scavenging capacity of pentoxiphylline and piracetam may be of value in the treatment of patients with cerebrovascular disorders, but merits further investigations.
机译:氧自由基在一些生理和病理生理过程中起着重要作用。在病理情况下,它们会改变和破坏生物系统。由于氧自由基与多种疾病(脑血管,心血管等)有关,因此清除这些自由基应被视为一种重要的治疗方法。在我们的体外研究中,我们研究了三种药物的抗氧化能力:己糖茶碱(西格玛奥德里奇,美国密苏里州圣路易斯),吡乙酰胺(西格玛奥德里奇)和长春西汀(Richter Gedeon RT,匈牙利布达佩斯)。甲基硫酸吩嗪被用于产生自由基,从而增加了红细胞的刚度。过滤技术和钾泄漏用于检测细胞损伤和所检查药物的清除作用。根据我们的结果,在人类治疗性血清浓度下,只有长春西汀(Richter Gedeon RT)具有明显的(p <0.01)清除活性,并在更高的浓度下具有进一步的保护作用。己酮可可碱(Sigma Aldrich)和吡拉西坦(Sigma Aldrich)在治疗浓度下没有明显的抗氧化能力,但增加它们的浓度(戊氧茶碱为100倍,吡拉西坦为高10倍)导致显着(p <0.01)清道夫效应。我们的研究结果表明,长春西汀的这种明显的抗氧化作用,甚至更广泛的清除己托西林和吡乙酰胺的清除能力,在治疗脑血管疾病患者中可能有价值,但值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号